Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Apparent benefits of after are

does not reproducibly under . Comparisons that control would show no or benefit, and independently fitted would fail .

Omega Point 1.1

Stage of verification

  1. Hypothesis published2026-09-18
  2. Not enough research data
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionBrain and nervous system

Biological function

Cognitive performance and learning through repeated task performance, assessed here in relation to testing phase and schedule alignment.Cognition and learning

Direction

Lens

Puts the cause in the measurement rather than the biology: the instrument, or the definition of what is being counted, produces the result.Measurement and interpretation

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Goal
Minimum Cumulative Tissue Replacement Set, Mass, and Functional-Unit Fraction Identification
Published
2026-09-18
Engine version
Omega Point 1.1
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
10 / 10Completeness of the answer
3 / 10Novelty of the idea
7 / 10Few new entities
7 / 10Decisive experiment
0 / 10Silver-bullet potential
Not ratedSupport from research
Poster: Measurement artifacts mimic alignment benefits
PosterOpen the sheet full size2026-09-18

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Indicator or biomarker

    Cognitive performance measurements

    Scores and observations used to assess cognitive performance

    Where this hypothesis actsTesting apparent timing-mediated after

    Hypotheses on this target 2
    Cognitive performance measurementsTelling states apart. Hypotheses on this target 22Direct measurement. Hypotheses on this target 0Indicator replacement. Hypotheses on this target 0
    • Telling states apart2
    • Direct measurement
    • Indicator replacement

    What is proposed

    Telling states apart

    Distinguish cognitive improvement from testing-, practice and selection effects

    With whatInstrument or assay

    HowUse , comparisons, matched challenges, alternate , and retention of all assigned episodes

    Possible result

    Expected absence of cognitive improvement, with excluding the prespecified effect

    From the recordApparent improvement is produced by testing cognition at a favorable phase, learning repeated tasks, regression after selecting unusually poor recovery episodes, and assessing aligned schedules under milder challenges.

  2. Indicator or biomarker

    Nyquist stability boundary

    A model-derived boundary between stable and unstable responses in a feedback loop

    Where this hypothesis actsPredicting timing-mediated after

    Hypotheses on this target 2
    Nyquist stability boundaryTelling states apart. Hypotheses on this target 22Direct measurement. Hypotheses on this target 0Indicator replacement. Hypotheses on this target 0
    • Telling states apart2
    • Direct measurement
    • Indicator replacement

    What is proposed

    Telling states apart

    Test independently fitted stability predictions on held-out episodes

    With whatInstrument or assay

    HowFit independently and evaluate their predictions on held-out episodes

    Possible result

    Expected failure of independently fitted to predict held-out outcomes

    From the recordNyquist boundaries appear predictive because gains and delays are fitted retrospectively to the same outcome-selected episodes.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burdenCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundary

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Partial organ replacement sometimes fails to restore function when the transplanted fraction is too small, and schedule adjustments — shifting meals, sleep, and activity to match the graft's internal clock — have been proposed as a way to that failure without adding tissue. This hypothesis rejects that possibility entirely: it proposes that every reported improvement from is an artifact of biased measurement, not a physiological . The unexpected position is not that timing matters less than expected, but that the phenomenon does not exist at all — apparent benefits arise from testing at favorable times of day, practice on repeated tasks, after selecting the worst episodes, and fitting to the data they claim to predict. This account was generated by a research pipeline as one of several competing explanations and has not been tested in a controlled experiment designed to detect these specific artifacts.

The proposed mechanism, link by link
  1. produces episodes of highly variable recovery quality across recipients and timepoints
  2. Researchers or study protocols select unusually poor recovery episodes as candidates for timing-alignment intervention
  3. toward the population mean inflates apparent improvement on retesting, regardless of whether any intervention was applied
  4. Cognitive outcome tests are administered at the when the schedule-aligned group naturally scores higher, inflating the between-group difference
  5. Repeated administration of the same across sessions introduces practice-driven that are credited to the timing intervention
  6. Aligned-schedule conditions happen to face milder physiological challenges — lower solute loads, smaller posture shifts, gentler activity demands — than misaligned conditions, confounding the comparison
  7. Nyquist are fitted to the same they claim to forecast, producing apparent predictive power that fails on data not used in the fit
A picture for it

Imagine judging whether a new alarm clock improves a student's grades by comparing their worst week's scores to scores on easier quizzes taken at their best time of day — the improvement looks convincing, but the comparison was never fair because the before-and-after differed in difficulty, timing, and which results were counted.

Where the picture breaks: A student's test performance has no physiological coupling to an alarm clock, whereas a transplanted organ may genuinely interact with the host's circadian signals through hormone and nerve pathways; the analogy captures the measurement bias but cannot represent the biological plausibility that a real timing effect might exist alongside the artifacts.

  1. Master questionstep 01 of 04

    Aging might be slowed by replacing worn or damaged tissue, but the question is how little replacement is sufficient and which specific parts must be swapped — the minimum set that would extend lifespan.

    Rests on: The premise that aging is, at least in part, a problem of tissue deterioration that physical replacement could address.

    Assumption

    Assumes tissue replacement is a viable route to slowing aging, which is not established by any supplied source.

  2. Goal pillarstep 02 of 04

    The goal narrows to identifying the smallest cumulative set of tissues — measured by total mass and by the fraction of each organ's , the smallest structural components that perform an organ's characteristic work — whose replacement would be enough to slow aging.

    Rests on: The master question's framing that a minimum replacement set exists and can be quantified.

    Stated in the chain
  3. Gap questionstep 03 of 04

    If a is failing because not enough was replaced, could simply realigning the recipient's daily schedule — meals, posture, activity — to the graft's internal circadian clock function without adding more tissue? And does the , a principle from control engineering that defines when a feedback system's corrections become too slow or too late to maintain stability, predict when ordinary schedule shifts would undo that ?

    Rests on: The goal of minimizing replacement mass: if can compensate for insufficient tissue, the minimum replacement set shrinks, making this a direct lever on the master question.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    The timing does not exist. Every apparent improvement attributed to schedule alignment after is produced by four artifacts acting together: cognitive tests administered at the — the point in the roughly 24-hour internal clock cycle — when the aligned group naturally performs best, practice effects from repeating the same across sessions, statistical toward average outcomes after selecting unusually poor recovery episodes for study, and evaluation of aligned schedules under less demanding physiological challenges than misaligned ones. The Nyquist stability boundaries that appear to predict when succeeds or fails are to the same , not validated on independent held-out data. No common mechanism exists; the coherent-looking pattern is an artifact of measurement and selection.

    Rests on: The gap question's assumption that there is a real timing-mediated to explain — this hypothesis answers that the assumption is false and that well-known experimental artifacts are sufficient to generate the reported evidence.

    Stated in the chain

What is carried, and what is not. Each individual artifact the hypothesis names — , -of-testing bias, practice effects on repeated tasks, retrospective model overfitting — is a well-documented methodological phenomenon in clinical and behavioral research. However, no supplied source demonstrates that these artifacts actually account for published timing- data in any tissue-replacement model. The two screened sources address circadian immune biology (S3, a 2013 review in Nature Reviews Immunology) and failed microbiota transfer of circadian fasting benefits (S6, a 2025 rodent study in the Journal of Cerebral Blood Flow and Metabolism) but neither tests whether timing-alignment improvements survive , artifact-controlled designs. The chain as a whole rests on the plausibility of known biases, not on any direct measurement of their contribution to the specific observations it seeks to explain.S3S6

Where the reasoning is carried by something unstated · 1
  • Master question. Assumes tissue replacement is a viable route to slowing aging, which is not established by any supplied source.
How a result here could mislead · 3
  • An study finds no statistically significant effect and is taken as evidence the phenomenon does not exist, when the sample was too small to detect a real but modest effect — the hypothesis itself flags this risk, but a future reader of the null result may not. What closes it: Confidence intervals must exclude the prespecified effect size before declaring absence; sample size must be justified by a prospective power calculation against that threshold, registered before enrollment begins.
  • Matching could inadvertently eliminate the physiological variation through which a real timing operates — for instance, clamping fluid intake or stabilizing ambient temperature — so that a null result reflects successful removal of the mechanism's input rather than absence of the mechanism itself. What closes it: Challenge-matching criteria must be defined as manipulations of schedule parameters (meal timing, activity timing, posture shifts) rather than elimination of the physiological stressors that the rival hypotheses propose as pathways; the protocol must specify which physiological variables are allowed to vary and which are held constant, with justification for each constraint.
  • In a , where each subject receives both conditions in sequence, the first condition's effect may persist into the second period — as the cross-domain transfer rival hypothesis predicts when cells cross a developmental state boundary that does not easily reverse — making both periods look equivalent and hiding a real . What closes it: Carryover washout periods must be long enough to accommodate the slowest proposed persistence mechanism among the competing hypotheses, and a parallel-group arm run alongside the crossover can detect carryover directly by comparing the crossover's second-period estimates to the parallel arm's single-period estimates.

What would make this wrong. A preregistered, adequately powered experiment using testing times, non-repeating , retention of all assigned episodes regardless of baseline severity, matched across conditions, and prospectively fitted Nyquist validated on held-out data — showing a , replicable improvement in or from schedule alignment after , with the stability model predicting and failure in episodes it was not trained on.

What it would change. If the timing is genuinely artifactual, the minimum tissue replacement set identified by the master question cannot be reduced by schedule alignment — the answer depends entirely on how much tissue is physically replaced, with no shortcut through circadian coordination. Every published report claiming that schedule adjustments compensated for insufficient graft mass would require reexamination under artifact-controlled designs, and the four rival hypotheses proposing real mechanisms for the would lose their motivating observation. Even a clean null result under full , however, would apply only to the specific organ, species, replacement fraction, and schedule parameters tested; generalization to the full parameter space of the master question — which tissues, which fractions, which organisms — would demand systematic replication that no single experiment provides.

Sources read · 2

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S3Background

Circadian control of the immune system. · Nature reviews. Immunology · 2013

“Cyclical homing and mobilization efficiencies of HSCs could be clinically exploited to enhance the isolation of mobilized HSCs at the acrophase in blood (which occurs at night in humans) . These cells should then be transplanted back at the peak of HSC homing activity to the bone marrow, which is predicted to be during the day in humans .”

Does not settle: The source does not address whether timing-aligned benefits are measurement artifacts, does not study cognition or partial tissue replacement rescue, reports no controlled experiment testing aligned versus misaligned schedules in a replacement model, and provides no data on regression artifacts, repeated-task learning, episode selection, or Nyquist-boundary curve-fitting. It is a mechanistic review of circadian immune biology, not an artifact-testing study.

S6Partly answers it

Fecal microbiota transplantation fails to impart the benefits of circadian-dependent intermittent fasting following ischemic stroke. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025

“fecal microbiota transplantation (FMT) from IIF or AIF cohort had no significant effects on post-ischemic motor and cognitive function recovery, anxiety-, and depression-like behaviors compared with FMT from AL cohort. Furthermore, FMT from IIF or AIF cohort did not influence the post-ischemic infarct volume, atrophy volume or white matter damage.”

Does not settle: The paper establishes only that circadian-phase-dependent IF benefits are not transmitted via gut microbiota transplant in a rodent focal ischemia model; it does not address whether timing alignment produces benefits through non-microbiota pathways (the original IF cohorts still showed circadian-dependent changes in F/B ratio and short-chain fatty acids). It says nothing about measurement artifacts, favorable-phase testing, task-learning confounds, regression to the mean, or retrospective Nyquist fitting — the specific artifact mechanisms the question names. The domain (microbiota transplant post-stroke) may not map onto whatever partial tissue replacement the question concerns. Sample sizes, species, and endpoint selection are not characterised in the retrieved text.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Can daily rhythm retiming a partial organ replacement, and when do routine activities undo it?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Can a failing without adding tissue, and does the predict when ordinary meal, posture, and activity shifts reverse that ?

What this question is asking

When an organ is only partly replaced — less tissue put in than was lost — the body may lack the raw capacity to keep itself stable. This question asks whether carefully adjusting the timing of the body's daily cycles (when a person eats, sleeps, stands, and moves) could squeeze enough performance out of the remaining tissue to avoid the need for more. It then asks a second, sharper thing: whether an engineering formula designed to predict when feedback systems tip into instability can forecast the exact point at which ordinary, uncontrolled shifts in meals, posture, or activity would overwhelm that timing fix and send the system back into failure. The question assumes that some of what looks like missing tissue is actually intact capacity thrown out of sync, and that separating the two is both possible and quantifiable.

What the terms mean
Reduced-fraction replacement
Replacing less than the full volume or cell count of a damaged or aged organ — implanting, for example, 40% of a kidney's worth of tissue rather than a whole kidney. The question treats this as a defined strategy and asks whether the shortfall can be compensated by means other than adding more tissue.
Physiological phase realignment
Adjusting the timing of the body's daily biological rhythms — when blood pressure peaks, when kidneys excrete sodium most actively, when hormones are released — so that the remaining organ capacity is deployed when the body needs it most. The idea is that a reduced organ working in sync with demand might perform as well as a larger organ working out of sync.
Nyquist stability criterion
A mathematical test from control engineering that determines whether a feedback system with time will remain stable or oscillate out of control. It examines the relationship between how strongly the system amplifies signals (gain) and how long it takes signals to travel around the feedback loop (delay). In this question it is proposed as a tool for predicting when everyday perturbations would push a -realigned physiological system past its stability margin — an application not established in the read sources.
Gain-delay boundary
The threshold combination of signal amplification and feedback delay beyond which a system becomes unstable. In the context of this question, it is the hypothetical line separating conditions under which a partial organ replacement can maintain stable function from conditions under which it cannot. The question asserts that this boundary is currently unknown.
Circadian blood-pressure dipping
The normal pattern in which blood pressure falls by 10–20% during nighttime sleep compared to daytime waking levels. A person whose pressure drops normally is called a 'dipper'; one whose pressure stays elevated at night is a 'non-dipper'. S1 reports that patients with reduced renal reserve lose this dipping pattern, especially under high salt intake, and can regain it with salt restriction.
Renal functional reserve
The kidney's surplus filtering capacity beyond what is needed at rest — the headroom that allows it to handle extra salt, protein, or fluid without blood pressure rising. When this reserve is reduced (by disease, aging, or surgical loss of kidney tissue), the kidney can maintain baseline function but fails under stress, and its daily excretory rhythms are disrupted.
Salt-sensitive hypertension
A form of high blood pressure in which blood-pressure levels rise and fall significantly with changes in dietary salt intake. S1 identifies it as a consequence of reduced renal reserve: the kidney cannot excrete sodium fast enough during the day and compensates by maintaining elevated pressure at night to force excretion, abolishing the normal circadian dip.
Ultrafiltration capacity
The kidney's ability to filter blood plasma across its glomerular capillaries — the first physical step in urine formation. Reduced ultrafiltration capacity is one of the two mechanisms S1 identifies as causing salt-sensitive hypertension when renal reserve is diminished.
What the question takes for granted
Premise only partly supported
There exists usable organ capacity that is lost not because tissue is missing but because daily physiological rhythms are misaligned, and an engineering stability criterion can quantify the boundary between recoverable misalignment and genuine tissue deficit.

The question assumes two things. First, that when a partial organ replacement underperforms, part of the shortfall comes from the remaining tissue working out of with the body's needs — not from an absolute shortage of cells. Second, that a mathematical tool from control engineering (one that predicts when a system with delayed feedback will oscillate out of control) can be applied to human physiology to draw a line between fixable timing problems and irreversible tissue loss. If the first assumption is wrong, retiming rhythms cannot help. If the second is wrong, there is no principled way to predict when everyday perturbations would destabilise the fix.

S1 establishes that reduced kidney reserve does disrupt circadian blood-pressure and sodium-excretion rhythms, and that dietary salt restriction can partly restore the normal day-night pattern — providing indirect support for the idea that timing-related dysfunction accompanies reduced organ capacity and that behavioural changes (salt intake) can modulate it. However, S1 does not frame this as recoverable capacity versus missing tissue, does not apply any control-theoretic model, does not reference the Nyquist criterion or any stability boundary, and does not test whether the restored rhythm translates into functional organ . The engineering half of the premise — that a gain-delay stability formula applies to these physiological feedback loops — has no support in the read sources.S1

The same question asked without the part nothing read establishes:

  • In organs with reduced functional reserve, does restoring normal circadian rhythms of excretion and blood pressure improve measurable organ performance, and how large are the relative to the capacity lost?
  • What is the quantitative relationship between circadian rhythm disruption and functional deficit in organs operating below full capacity, and how much of that deficit is reversible by behavioural timing changes?
  • How robust is a circadian-rhythm restoration in a reduced-capacity organ to everyday perturbations such as variable meal timing, posture changes, and physical activity?
What turns on the answer
  • partial replacement and stability is predictable If retiming daily rhythms can genuinely compensate for missing tissue, the minimum replacement threshold drops: surgeons or tissue engineers could implant less material and rely on post-operative rhythm protocols (scheduled meals, sleep, activity) to close the performance gap. If, further, a stability formula reliably predicts when everyday disruptions would overwhelm the fix, clinicians could prescribe quantitative lifestyle boundaries — a maximum salt load, a postural-change rate, an exercise ceiling — personalised to each patient's remaining reserve. The practical consequence is smaller, safer procedures with a defined operating envelope.
  • helps but stability is unpredictable If rhythm retiming improves function but no formula predicts when routine activities destabilise it, the fix is real but ungovernable. A patient might do well for weeks under controlled conditions and then collapse after an unremarkable meal or a flight of stairs, with no prior warning and no way to set safe limits. Clinicians would face a choice between prescribing impractically rigid schedules or accepting an unknown failure risk, and the minimum-replacement question would remain unanswerable in practice despite the theoretical gain.
  • does not partial replacement If the circadian disruption seen in reduced-reserve organs is a downstream symptom rather than a recoverable capacity loss, retiming rhythms would improve markers like blood-pressure dipping without restoring organ function. The minimum tissue threshold would then be set entirely by the mass of functioning cells, timing protocols would be irrelevant to the replacement question, and the engineering stability framework would have no physiological object to model. Research effort spent on as a tissue-sparing strategy would be misdirected.
Why it matters

If partial organ replacement fails not because there is too little tissue but because the remaining tissue is working at the wrong time of day, the minimum replacement threshold — how much tissue must be transplanted or regenerated — could be lower than currently assumed, provided the recipient's daily rhythms are re-synchronised. Getting this wrong in one direction means replacing tissue that was never needed, carrying the surgical and immunological cost for nothing. Getting it wrong in the other direction means declaring a timing fix sufficient when the tissue genuinely is not there, which would leave the recipient in progressive organ failure. The second part of the question raises the further risk that a timing fix that works under controlled conditions could collapse the moment a patient skips a meal, stands up quickly, or exercises — and that without a quantitative stability boundary, no one can say how fragile the fix is.

What is already established

RL-1 suggest coordination effects; established supplies no validated replacement-specific .

What would have to be true

Reduced-fraction candidates maintain recovery and within across ordinary exposures and .

What is missing

Unknown prevent distinguishing missing tissue from usable capacity lost through .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

PHENOMENON-DOESN'T-EXIST: has no reproducible timing-mediated under . Apparent improvement is produced by testing at a favorable , learning repeated tasks, after selecting unusually poor recovery episodes, and assessing aligned schedules under milder challenges. appear predictive because and are to the same . The purported common mechanism is an artifact of measurement and selection.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

In , comparisons with matched , alternate , , and all assigned episodes retained, alignment produces no improvement in or . Independently fitted fail . must exclude the prespecified meaningful effect; a result is insufficient. Reproducible effects predicted by any of IH_01 through IH_04 this account.

Would tell it apart from at least one rival. The prediction specifies assessable intervention outcomes, held-out predictive failure, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

These can be embedded in animal and safe . must accommodate both and the of IH_02.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.